01244.HK
3D Medicines Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.46
−2.00%Margins
Gross margin
85.6%
EBITDA margin
-39.6%
EBIT margin
-24.0%
Net margin
-42.4%
FCF margin
-18.6%
-65.2%
Return on equity
-36.5%
Return on assets
-27.8%
Return on invested capital
0.86x
Asset turnover
-HKD 174.7M
Cash from operations
HKD 1.87
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026